← Eichor
Condition: Malaria Infection Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Malaria Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

DON in Pediatric Cerebral Malaria
Phase 1/Phase 2 · 2 location(s) · Douglas Postels, MD, MS · NCT05478720Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910Field Trial of PfSPZ-LARC2 Vaccine in Burkinabe Adults
Phase 2 · 1 location(s) · Sanaria Inc. · NCT07385287Primaquine for Vivax Malaria in G6PD Intermediate and Deficient Cases.
Phase 4 · 4 location(s) · Menzies School of Health Research · NCT07468513L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
NA · 1 location(s) · Liverpool School of Tropical Medicine · NCT05934318PDMC Implementation Trial in Kenya
Phase 4 · 1 location(s) · Liverpool School of Tropical Medicine · NCT06624631Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants
Phase N/A · 1 location(s) · Amivas Inc. · NCT05285735Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00001645Assessing the Feasibility of Combining Dihydroartemisinin Piperaquine and Primaquine for Malaria Mass Drug Administratio
NA · 1 location(s) · Noguchi Memorial Institute for Medical Research · NCT07389057Safety and Efficacy of Imatinib in Combination With Artemether-Lumefantrine for Uncomplicated Malaria
Phase 2 · 1 location(s) · Victoria Biomedical Research Institute · NCT07559370Malaria Molecular Surveillance in Mozambique (Phase 2)
Phase N/A · 1 location(s) · Centro de Investigacao em Saude de Manhica · NCT06529237ACT vs CQ With Tafenoquine for P. Vivax Mono-infection
Phase 4 · 1 location(s) · Shoklo Malaria Research Unit · NCT05788094Drug-Interaction Assessment of GSK3772701 in Healthy Male and Female Participants Aged 18 to 55 Years
Phase 1 · 1 location(s) · GlaxoSmithKline · NCT07670377PfSPZ-LARC2 Vaccine in Women of Child-bearing Potential (WOCBP) in Mali
Phase 2 · 1 location(s) · Sanaria Inc. · NCT07675785Mass Vaccine and Drug Administration, Bangladesh
Phase 4 · 2 location(s) · University of Oxford · NCT06068530Investigating the Pharmacokinetics of Tafenoquine in Healthy Papua New Guinean Children
Phase 4 · 1 location(s) · Curtin University · NCT07052162A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 Combined With R21/Matrix-M (a "Multi-stage" Malaria V
Phase 1 · 1 location(s) · University of Oxford · NCT06958198Safety, Tolerability and Efficacy of PfSPZ-LARC2 Vaccine Against CHMI in Malaria-Naïve Adults
Phase 1 · 1 location(s) · Sanaria Inc. · NCT06862453Post-discharge Malaria Chemoprevention Implementation Trial in Benin
Phase 4 · 2 location(s) · Institut de Recherche Clinique du Benin · NCT06601712Platelet-Directed Whole Blood Transfusion Strategy for Malaria
NA · 2 location(s) · Johns Hopkins Bloomberg School of Public Health · NCT05711485Induced Blood-Stage Malaria in Healthy Malaria-Naive Adults to Assess the Safety and Infectivity of Plasmodium Vivax Cha
Phase 1 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06607003Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT03937817Effectiveness of Malaria Vaccines in Reducing the Risk of Invasive Non-typhoidal Salmonella Disease
Phase N/A · 1 location(s) · International Vaccine Institute · NCT07416461Strengthening the Evidence for Policy on the RTS,S/AS01 Malaria Vaccine
Phase N/A · 4 location(s) · Kintampo Health Research Centre, Ghana · NCT05041556Physiology and Pathologies Linked to Human Splenic Function : Direct and Ex-vivo Perfusion Explorations
Phase N/A · 5 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06418256Introduction of Polymerase Chain Reaction (PCR) in Microbiology and Parasitology
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07269314Host and Parasite Factors That Influence Susceptibility to Malaria Infection and Disease During Pregnancy and Early Chil
Phase N/A · 2 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT01168271Comparison of Two Strategies for Administering the R21-Matrix M Vaccine in a Context of Seasonal Malaria Transmission in
Phase 4 · 1 location(s) · Epicentre · NCT07038837Evaluation of Artesunate in Infants Being Treated for Severe Malaria
Phase N/A · 1 location(s) · Amivas Inc. · NCT06555809An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are Taken
Phase 3 · 4 location(s) · GlaxoSmithKline · NCT06666491
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.